Moolec Science SA (MLEC) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators suggest bearish trends, and there are no significant positive catalysts or trading signals to support immediate entry. While the company has shown impressive revenue growth, its financials still reflect negative net income and gross margin deterioration. With no recent news or analyst ratings, and neutral sentiment from hedge funds and insiders, it is better to wait for clearer positive signals before investing.
The MACD is below 0 and negatively contracting, indicating bearish momentum. The RSI is neutral at 41.089, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 7.573, with key support at 6.917 and resistance at 8.228.
Revenue increased by 948.32% YoY in Q2 2025, reflecting significant top-line growth.
No recent news, trading trends, or congress activity to drive sentiment.
In Q2 2025, revenue surged by 948.32% YoY to $2,642,964. However, net income remains negative at -$2,427,307, albeit improving by 36.10% YoY. EPS also improved to -9.35 (up 32.06% YoY), but gross margin deteriorated significantly to -25.78% (down -133.20% YoY).
No analyst ratings or price target changes available.
